---
title: "Genomic survey reveals extensive biosynthetic gene clusters in Bionectriaceae cacao endophytes"
id: "biorxiv-0-remarkable-biosynthetic-diversity-in-the-bionectriaceae-uncovering-the-genomic"
canonical_url: "https://medichelpline.com/clinical-feed/biorxiv-0-remarkable-biosynthetic-diversity-in-the-bionectriaceae-uncovering-the-genomic"
content_type: "clinical_feed_article"
specialty: "Pharmacology"
source_name: "bioRxiv (Biomedical Preprints)"
source_url: "https://www.biorxiv.org/content/10.64898/2026.11.16.767117v1?rss=1"
published_at: "2026-11-22T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Genomic survey reveals extensive biosynthetic gene clusters in Bionectriaceae cacao endophytes
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/biorxiv-0-remarkable-biosynthetic-diversity-in-the-bionectriaceae-uncovering-the-genomic
- **Specialty:** [Pharmacology](https://medichelpline.com/clinical-feed/pharmacology.md)
- **Primary Source:** bioRxiv (Biomedical Preprints)
- **Source URL:** [Original Journal Publication](https://www.biorxiv.org/content/10.64898/2026.11.16.767117v1?rss=1)
- **Published At:** 2026-11-22T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- The study sequenced two cacao pod endophytes, **Clonostachys rosea** TCF417 and **Waltergamsia zeylanica** TCF400, to identify biosynthetic gene clusters (BGCs) that may underlie antifungal activity. - Investigators used Oxford Nanopore and Illumina sequencing to assemble genomes reported as 52.9 Mb for C. rosea TCF417 and 31 Mb for W. zeylanica TCF400; the source did not report additional assembly metrics in the abstract. - Genome annotation employed Funannotate and BGC prediction used antiSMASH; BiG-SCAPE provided comparative clustering against 30 public **Bionectriaceae** genomes. - The two cacao isolates carried 92 BGCs in total (67 in C. rosea, 25 in W. zeylanica), reflecting high biosynthetic diversity relative to available family genomes. - Across 32 genomes, investigators identified 1,523 BGC-containing regions; Type I PKS clusters were the most common class observed in the dataset presented. - Network clustering grouped BGCs into 209 gene cluster families (GCFs); 52 of those matched previously characterized BGCs while roughly 75% remained unassigned to known families. - Conserved BGCs predicted to encode antifungal natural products, including sorbicillinoids and verticillins, were present in the cacao endophytes and elsewhere in the family. - The study team performed an antifungal assay showing that verticillin D from C. rosea TCF417 inhibited growth of plant pathogens **Moniliophthora roreri** and Mycena citricolor; specific assay conditions and concentrations were not reported in the abstract. - Authors conclude the **Bionectriaceae** harbor a largely untapped biosynthetic repertoire; the preprint status indicates findings have not undergone peer review and many GCFs remain uncharacterized. - Key unanswered questions include the full chemical identities of unassigned GCF products, the genetic determinants of observed antagonism beyond verticillin D, and ecological roles of these metabolites in cacao endophyte–pathogen interactions.
## Clinical Analysis & Structured Key Points
[Skip to main content](https://www.biorxiv.org/content/10.64898/2026.11.16.767117v1?rss=1#main-content) [![bioRxiv](https://www.biorxiv.org/sites/default/files/biorxiv_article_logo.jpg)](https://www.biorxiv.org/) * [Home](https://www.biorxiv.org/) * [Submit](https://www.biorxiv.org/submit-a-manuscript) * [FAQ](https://www.biorxiv.org/about/FAQ) * [Blog](https://connect.biorxiv.org/news/) * [ALERTS / RSS](https://www.biorxiv.org/content/alertsrss) * [Resources](https://connect.biorxiv.org/resources/) * [About](https://www.biorxiv.org/content/about-biorxiv) * [Channels](https://www.biorxiv.org/content/10.64898/2026.11.16.767117v1?rss=1) * [4D Nucleome](https://connect.biorxiv.org/relate/content/66) * [Academia Sinica](https://connect.biorxiv.org/group/content/38) * [Advances in Genome Biology and Technology (AGBT) General Meeting 2016 #AGBT16](https://connect.biorxiv.org/relate/content/10) * [Albert Einstein College of Medicine](https://connect.biorxiv.org/group/content/4) * [Aligning Science Across Parkinson's (ASAP)](https://connect.biorxiv.org/relate/content/195) * [Allen Institute for Cell Science](https://connect.biorxiv.org/relate/content/71) * [Arc Institute](https://connect.biorxiv.org/relate/content/224) * [Babraham Institute](https://connect.biorxiv.org/relate/content/197) * [BICCN/BICAN](https://connect.biorxiv.org/relate/content/208) * [BioImaging North America](https://connect.biorxiv.org/relate/content/194) * [Biology of Genomes 2016 #BOG16](https://connect.biorxiv.org/relate/content/19) * [Breakthrough Discoveries for Thriving with Bipolar Disorder](https://connect.biorxiv.org/relate/content/236) * [Brown University](https://connect.biorxiv.org/group/content/9) * [California Institute of Technology](https://connect.biorxiv.org/group/content/32) * [Carnegie Mellon University](https://connect.biorxiv.org/group/content/19) * [Case Western Reserve University](https://connect.biorxiv.org/group/content/36) * [Central Oxford Structural Microscopy and Imaging](https://connect.biorxiv.org/relate/content/143) * [Centre for Microbiology and Environmental Systems Science](https://connect.biorxiv.org/relate/content/190) * [Chan Zuckerberg Biohub](https://connect.biorxiv.org/relate/content/121) * [Columbia University](https://connect.biorxiv.org/group/content/27) * [Donders Institute for Brain, Cognition and Behaviour](https://connect.biorxiv.org/relate/content/184) * [DREAM](https://connect.biorxiv.org/relate/content/153) * [Drug Development and Clinical Therapeutics](https://connect.biorxiv.org/relate/content/52) * [ENCODE](https://connect.biorxiv.org/relate/content/177) * [Ernst Strüngmann Institute (ESI) for Neuroscience](https://connect.biorxiv.org/relate/content/211) * [European Molecular Biology Laboratory (EMBL)](https://connect.biorxiv.org/relate/content/159) * [Francis Crick Institute](https://connect.biorxiv.org/relate/content/88) * [Fred Hutchinson Cancer Center](https://connect.biorxiv.org/group/content/28) * [Georgia Institute of Technology](https://connect.biorxiv.org/group/content/20) * [Harvard Program in Therapeutic Sciences](https://connect.biorxiv.org/relate/content/151) * [The Howard Hughes Medical Institute (HHMI)](https://connect.biorxiv.org/relate/content/227) * [Human Cell Atlas](https://connect.biorxiv.org/relate/content/163) * [Human Pangenome Reference Consortium (HPRC)](https://connect.biorxiv.org/relate/content/215) * [IMO Workshop](https://connect.biorxiv.org/relate/content/8) * [Impact of Genomic Variation on Function (IGVF)](https://connect.biorxiv.org/relate/content/214) * [Institut Pasteur](https://connect.biorxiv.org/relate/content/235/channel) * [Institute of Science and Technology Austria](https://connect.biorxiv.org/group/content/12) * [International Human Epigenome Consortium (IHEC)](https://connect.biorxiv.org/relate/content/219) * [International Mouse Phenotyping Consortium (IMPC)](https://connect.biorxiv.org/relate/content/185) * [Iowa State University](https://connect.biorxiv.org/group/content/6) * [Johns Hopkins University](https://connect.biorxiv.org/group/content/47) * [Mathematical Oncology](https://connect.biorxiv.org/relate/content/1) * [Micron Oxford](https://connect.biorxiv.org/relate/content/116) * [Michigan State University](https://connect.biorxiv.org/group/content/7) * [Morgridge Institute](https://connect.biorxiv.org/group/content/57) * [National Taiwan University](https://connect.biorxiv.org/group/content/39) * [NCI Cancer Systems Biology Consortium](https://connect.biorxiv.org/relate/content/210) * [NF Open Science Initiative](https://connect.biorxiv.org/relate/content/213) * [NCI Human Tumor Atlas Network](https://connect.biorxiv.org/relate/content/171) * [Neuromatch Conference](https://connect.biorxiv.org/relate/content/209) * [NeurotechEU](https://connect.biorxiv.org/relate/content/189) * [North Carolina State University](https://connect.biorxiv.org/group/content/37) * [Northeastern University](https://connect.biorxiv.org/group/content/54) * [Oregon Health & Sciences University](https://connect.biorxiv.org/group/content/22) * [RNA Therapeutics Institute at UMass Chan Med School](https://connect.biorxiv.org/relate/content/243) * [Rosetta Commons](https://connect.biorxiv.org/relate/content/191) * [Rutgers University](https://connect.biorxiv.org/group/content/31) * [SeroNet](https://connect.biorxiv.org/relate/content/192) * [Simons Foundation Autism Research Initiative (SFARI)](https://connect.biorxiv.org/relate/content/74) * [Society for Molecular Biology and Evolution #SMBE2016](https://connect.biorxiv.org/relate/content/29) * [Somatic Cell Genome Editing Program](https://connect.biorxiv.org/relate/content/167) * [Somatic Mosaicism across the Human Tissues Network](https://connect.biorxiv.org/relate/content/222) * [SPARC](https://connect.biorxiv.org/relate/content/187) * [Stowers Institute for Medical Research](https://connect.biorxiv.org/group/content/3) * [Stockholm University](https://connect.biorxiv.org/group/content/14) * [Tel Aviv University](https://connect.biorxiv.org/group/content/8) * [The Michael J. Fox Foundation](https://connect.biorxiv.org/relate/content/207) * [The Rockefeller University](https://connect.biorxiv.org/group/content/2) * [The Sainsbury Laboratory](https://connect.biorxiv.org/relate/content/98) * [The Whitehead Institute](https://connect.biorxiv.org/relate/content/212) * [University of Connecticut Health Center](https://connect.biorxiv.org/group/content/16) * [University of California, Berkeley](https://connect.biorxiv.org/group/content/13) * [University of California, San Diego](https://connect.biorxiv.org/group/content/41) * [University of California, San Francisco](https://connect.biorxiv.org/group/content/10) * [University of Chicago](https://connect.biorxiv.org/group/content/42) * [University of Geneva](https://connect.biorxiv.org/group/content/26) * [University of Guelph](https://connect.biorxiv.org/group/content/23) * [University of Hong Kong](https://connect.biorxiv.org/group/content/29) * [University of Illinois Chicago](https://connect.biorxiv.org/group/content/43) * [University of Iowa](https://connect.biorxiv.org/group/content/24) * [University of Kansas](https://connect.biorxiv.org/group/content/33) * [University of Massachusetts Chan Medical School](https://connect.biorxiv.org/group/content/44) * [University of New South Wales](https://connect.biorxiv.org/group/content/25) * [University of Ottawa](https://connect.biorxiv.org/group/content/35) * [University of Sydney](https://connect.biorxiv.org/group/content/50) * [Vanderbilt University](https://connect.biorxiv.org/group/content/30) * [Vienna BioCenter](https://connect.biorxiv.org/relate/content/186) * [Washington University in St. Louis](https://connect.biorxiv.org/group/content/11) * [Weizmann Institute of Science](https://connect.biorxiv.org/group/content/15) * [Yale University](https://connect.biorxiv.org/group/content/53) Search for this keyword [Advanced Search](https://www.biorxiv.org/search) New Results Follow this preprint # Remarkable Biosynthetic Diversity in the Bionectriaceae: Uncovering the genomic basis of antipathogen bioactivity of cacao fungal endophytes Clonostachys rosea and Waltergamsia zeylanica. [ View ORCID Profile](http://orcid.org/0000-0003-3668-5577)Librada Antonia Atencio, Hilda Elena Castillo, Masiel Barrios-Jaén, Indira Quintero, Andrea Martínez, Candelario Rodriguez, Marcelino Gutiérrez, Luis C. Mejía doi: https://doi.org/10.64898/2026.11.16.767117 This article is a preprint and has not been certified by peer review [[what does this mean?](https://www.biorxiv.org/about/FAQ#unrefereed)]. Librada Antonia Atencio 1 Instituto de Investigaciones Cientificas y Servicios de Alta Tecnologia de Panama; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Librada%2BAntonia%2BAtencio%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Atencio%20LA&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3ALibrada%2BAntonia%2BAtencio%2B) * [ORCID record for Librada Antonia Atencio](http://orcid.org/0000-0003-3668-5577 "Open in new tab") * For correspondence: latencio@indicasat.org.pa Hilda Elena Castillo 1 Instituto de Investigaciones Cientificas y Servicios de Alta Tecnologia de Panama; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Hilda%2BElena%2BCastillo%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Castillo%20HE&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AHilda%2BElena%2BCastillo%2B) Masiel Barrios-Jaén 1 Instituto de Investigaciones Cientificas y Servicios de Alta Tecnologia de Panama; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Masiel%2BBarrios-Ja%C3%A9n%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Barrios-Ja%C3%A9n%20M&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AMasiel%2BBarrios-Ja%25C3%25A9n%2B) Indira Quintero 1 Instituto de Investigaciones Cientificas y Servicios de Alta Tecnologia de Panama; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Indira%2BQuintero%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Quintero%20I&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AIndira%2BQuintero%2B) Andrea Martínez 1 Instituto de Investigaciones Cientificas y Servicios de Alta Tecnologia de Panama; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Andrea%2BMart%C3%ADnez%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Mart%C3%ADnez%20A&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AAndrea%2BMart%25C3%25ADnez%2B) Candelario Rodriguez 2 Estación Científica Coiba * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Candelario%2BRodriguez%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Rodriguez%20C&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3ACandelario%2BRodriguez%2B) Marcelino Gutiérrez 1 Instituto de Investigaciones Cientificas y Servicios de Alta Tecnologia de Panama; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Marcelino%2BGuti%C3%A9rrez%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Guti%C3%A9rrez%20M&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AMarcelino%2BGuti%25C3%25A9rrez%2B) Luis C. Mejía 1 Instituto de Investigaciones Cientificas y Servicios de Alta Tecnologia de Panama; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Luis%2BC.%2BMej%C3%ADa%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Mej%C3%ADa%20LC&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3ALuis%2BC.%2BMej%25C3%25ADa%2B) * [Abstract](https://www.biorxiv.org/content/10.64898/2026.11.16.767117v1)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_art/node:5986186/1) * [Info/History](https://www.biorxiv.org/content/10.64898/2026.11.16.767117v1.article-info)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_info/node:5986186/1) * [Metrics](https://www.biorxiv.org/content/10.64898/2026.11.16.767117v1.article-metrics)[](https://www.biorxiv.org/panels_ajax_tab/article_tab_metrics/node:5986186/1) * [ Preview PDF](https://www.biorxiv.org/content/10.64898/2026.11.16.767117v1.full.pdf+html)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:5986186/1) ![Loading](https://www.biorxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract Cacao (_Theobroma cacao_) production in tropical countries is threatened by fungal diseases caused by _Moniliophthora roreri_ and _M. perniciosa_. Two cacao pod endophytes from _Bionectriaceae_ , _Clonostachys rosea_ TCF417 and _Waltergamsia zeylanica_ TCF400, exhibit growth antagonism towards _M. roreri_ ; however, the genetic basis underlying the bioactivity of these strains has not been addressed. Here, we aimed to identify biosynthetic gene clusters (BGCs) potentially associated with the antifungal bioactivity of these two strains and performed a comparative analysis with 30 publicly available _Bionectriaceae_ genomes using BiG-SCAPE. Whole-genome sequencing using Oxford Nanopore and Illumina technologies, resulted in assemblies of 52.9 Mb (_C. rosea_ TCF417) and 31 Mb (_W. zeylanica_ TCF400). Genome annotation was conducted using Funannotate, and secondary metabolite BGCs were predicted using antiSMASH. The two cacao endophytes harbored 92 BGCs (_C. rosea_ : 67; _W. zeylanica_ : 25), indicating remarkable biosynthetic diversity. Across all 32 genomes, 1,523 BGC-containing regions were identified, most belonging to T1PKS clusters. Network-based clustering revealed 209 gene cluster families (GCFs), of which 52 corresponded to previously characterized BGCs. Conserved BGCs for antifungal compounds, including sorbicillinoids and verticillins, were identified in cacao endophytes and across _Bionectriaceae_. Additionally, an antifungal assay conducted here demonstrated that verticillin D from _C. rosea_ TCF417 exhibited growth inhibition of plant pathogens _Moniliophthora roreri_ and _Mycena citricolor_. With about 75% of unassigned GCFs, our results reveal a largely untapped biosynthetic repertoire in the _Bionectriaceae_ and identify verticillin D as a candidate contributor to the antagonism of _C. rosea_ against plant pathogens. Copyright The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a [CC-BY-NC-ND 4.0 International license](http://creativecommons.org/licenses/by-nc-nd/4.0/). bioRxiv and medRxiv thank the following for their generous financial support: > The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.biorxiv.org/content/10.64898/2026.11.16.767117v1?rss=1#page) [ Previous](https://www.biorxiv.org/content/10.64898/2026.11.20.768232v1 "Astrocyte-secreted Cathepsin D regulates hippocampal memory through extracellular matrix remodeling") Posted November 22, 2026. [ Download PDF](https://www.biorxiv.org/content/10.64898/2026.11.16.767117v1.full.pdf) Print/Save Options [Download PDF](https://www.biorxiv.org/content/biorxiv/early/2026/11/22/2026.11.16.767117.full.pdf)Full Text & In-line FiguresXML [More Info](https://www.biorxiv.org/about/FAQ#PrintOptions "More Information on Print/Save Options") [ Email](https://www.biorxiv.org/ "Email this Article") [ Share](https://www.biorxiv.org/) Remarkable Biosynthetic Diversity in the Bionectriaceae: Uncovering the genomic basis of antipathogen bioactivity of cacao fungal endophytes Clonostachys rosea and Waltergamsia zeylanica. Librada Antonia Atencio, Hilda Elena Castillo, Masiel Barrios-Jaén, Indira Quintero, Andrea Martínez, Candelario Rodriguez, Marcelino Gutiérrez, Luis C. Mejía bioRxiv 2026.11.16.767117; doi: https://doi.org/10.64898/2026.11.16.767117 This article is a preprint and has not been certified by peer review [[what does this mean?](https://www.biorxiv.org/about/FAQ#unrefereed)]. Share This Article: Copy [![Twitter logo](https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/twitter.png)](https://www.biorxiv.org/highwire_log/share/twitter?link=http%3A%2F%2Ftwitter.com%2Fshare%3Furl%3Dhttps%253A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.64898%2F2026.11.16.767117v1%26text%3DRemarkable%2520Biosynthetic%2520Diversity%2520in%2520the%2520Bionectriaceae%253A%2520Uncovering%2520the%2520genomic%2520basis%2520of%2520antipathogen%2520bioactivity%2520of%2520cacao%2520fungal%2520endophytes%2520Clonostachys%2520rosea%2520and%2520Waltergamsia%2520zeylanica. "Share this on Twitter") [![Facebook logo](https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png)](https://www.biorxiv.org/highwire_log/share/facebook?link=http%3A%2F%2Fwww.facebook.com%2Fsharer.php%3Fu%3Dhttps%253A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.64898%2F2026.11.16.767117v1%26t%3DRemarkable%2520Biosynthetic%2520Diversity%2520in%2520the%2520Bionectriaceae%253A%2520Uncovering%2520the%2520genomic%2520basis%2520of%2520antipathogen%2520bioactivity%2520of%2520cacao%2520fungal%2520endophytes%2520Clonostachys%2520rosea%2520and%2520Waltergamsia%2520zeylanica. "Share on Facebook") [![LinkedIn logo](https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/linkedin-32px.png)](https://www.biorxiv.org/highwire_log/share/linkedin?link=http%3A%2F%2Fwww.linkedin.com%2FshareArticle%3Fmini%3Dtrue%26url%3Dhttps%253A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.64898%2F2026.11.16.767117v1%26title%3DRemarkable%2520Biosynthetic%2520Diversity%2520in%2520the%2520Bionectriaceae%253A%2520Uncovering%2520the%2520genomic%2520basis%2520of%2520antipathogen%2520bioactivity%2520of%2520cacao%2520fungal%2520endophytes%2520Cl
## Related Clinical Research

- [Nuclear quantum effects on ion permeation through the TRPM7 open pore: continuum-electrostatics es](https://medichelpline.com/clinical-feed/biorxiv-1-nuclear-quantum-effects-on-ion-permeation-through-the-open-transient-receptor.md)
- [XPR1 phosphate selectivity driven by multi‑ion competition](https://medichelpline.com/clinical-feed/biorxiv-1-phosphate-selectivity-in-xpr1-is-driven-by-direct-multi-ion-competition.md)
- [Motherly Plus trial: Smartphone‑assisted single‑session psychotherapy for postpartum depression](https://medichelpline.com/clinical-feed/medrxiv-3-motherly-plus-study-protocol-of-a-randomized-controlled-trial-evaluating-a.md)
- [Plasma P-tau217, NfL and GFAP Predict Cognitive and Functional Decline in Early Sporadic Parkinson](https://medichelpline.com/clinical-feed/medrxiv-1-plasma-neurodegeneration-biomarkers-and-clinical-progression-in-early-sporadic.md)
- [Context-dependent roles of DJ-1 (PARK7) in oxidative-stress diseases: neuroprotection versus tumor](https://medichelpline.com/clinical-feed/pubmed-43059404.md) (DOI: 10.3892/mmr.2026.14076)

## Navigation
- [← Back to Pharmacology Feed](https://medichelpline.com/clinical-feed/pharmacology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.